We have investigated the molecular basis of the marked elevation in erythrocyte adenosine deaminase (ADA) activity in a kindred with hereditary hemolytic anemia. Red cell ADA-specific activity was verified to be 70-to 100-fold normal levels. Western blots demonstrated a corresponding increase in erythrocyte ADAspecific immunoreactive protein. Analysis of genomic DNA revealed no evidence for amplification or major structural changes in the ADA gene. ADA-specific messenger RNA (mRNA) from proband reticulocytes was comparable in size and amount to mRNA from control reticulocytes. Translation of proband poly A' reticulocyte mRNA in a rabbit reticulocyte lysate system and immunoprecipitation of 3_S-labeled protein products with anti-ADA antibody yielded a band of -42,000 apparent mol wt that was absent in translation products from control reticulocyte mRNAs. These data suggest that the increased ADA activity in red cells in this disorder results from the increased translation of an aberrant ADA mRNA.
Introduction
In 1970 Paglia et al. first described a kindred with a mild chronic hemolytic anemia and decreased adenine nucleotide pools (1) . The specific defect in the red blood cells (RBC)' was later shown to be a 45-to 70-fold elevation of erythrocyte adenosine deaminase (ADA) activity over normal values in association with a 50-75% depletion of ATP (2) . The abnormality appeared to be tissue-specific in that ADA activity in leukocytes and skin fibroblasts was normal. The defect was inherited as an autosomal dominant trait, affecting 12 of 24 family members at risk. txtensive studies of ADA partially purified from proband RBC revealed normal kinetic and physicochemical properties, suggesting that erythrocytes contain an increased amount of structurally normal ADA protein (3, 4) . Two 
additional kindreds
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with similar clinical and biochemical findings have since been described (5, 6) .
ADA is a purine catabolic enzyme that catalyzes the irreversible deamination of adenosine to inosine and 2'-deoxyadenosine to 2'-deoxyinosine. Deficiency of ADA has been causally associated with severe combined immunodeficiency disease, an autosomal recessive disorder characterized by B and T lymphocyte depletion (7) . The pathophysiology ofthis syndrome appears to be related to substrate accumulation and the selective metabolism of 2'-deoxyadenosine to its corresponding 2'-deoxynucleotides in lymphoid cells (8 Enzyme analysis. Cell extracts were assayed for ADA activity as previously described (14) .
DNA extraction and Southern blot analysis. DNA was extracted from proband and normal human whole blood by the method of Bell et al. (15) . Southern blot analysis was performed according to Maniatis (16) . Blots were hybridized with a 1.5-kb full-length ADA cDNA probe nick translated with 32P-dCTP to a specific activity of -108 cpm/gg.
RNA extraction and Northern blot analysis. Total RNA was extracted from reticulocyte-rich, leukocyte-depleted blood prepared as described above. Frozen RBC pellets were thawed in 4 vol of cold 5-mM magnesium chloride, stirred for 5 min with 0.1 vol triisopropylnaphthalenesulfonic acid sodium salt (Eastman Kodak Co., Rochester, NY), and extracted with phenolchloroform. The aqueous phase was adjusted to 0.3 M sodium chloride, reextracted with phenolchloroform, and precipitated overnight with 0.1 vol 3.0 M sodium acetate (pH 5.2) and 2 vol 100% ethanol. The precipitate was washed in 70% ethanol, reprecipitated, and suspended in water at a concentration of 1-3 mg/ml. Poly A' mRNA was purified by oligo-(dT) cellulose chromatography as described by Aviv and Leder (17) with modifications to eliminate sodium and SDS from buffers.
A proband lymphoblastoid cell line was established by Epstein-Barr virus-mediated transformation of peripheral blood B lymphocytes by Dr. Peter Daddona (18) . RNA was extracted from the proband and two normal B lymphoblast cell lines as well as from the MOLT-4 T lymphoblast cell line by centrifugation in a guanidium-cesium chloride gradient (16) .
Northern blot analyses were performed using formaldehyde denaturing gels (16) .
In vitro translation and immunoprecipitation. In vitro translation was performed in a rabbit reticulocyte lysate system (Amersham Corp., Arlington Heights, IL). Reactions were carried out in multiple aliquots containing 40 ,l ofreticulocyte lysate, 1 3 MCi 35S-methionine (1.1 mCi/ mmol), and 300-500 ng poly A' messenger RNA (mRNA). Mixtures were incubated for 1 h at 30°C. Reaction volumes were pooled and TCA-precipitable radioactivity determined on 5-Ml aliquots.
Immunoprecipitation of ADA was carried out according to the method of Kessler (19) . Pooled translation mixtures were diluted 1:2 in a buffer containing 25 mM Tris, 50 mM NaCI, 0.5% deoxycholate, and 1% NP-40 (pH 7.4) (Buffer A) and the proband sample was divided into two equal aliquots. Lysates were incubated for 1 h with 2 Ml rabbit preimmune serum at 4°C. Pansorbin (100 gl of a 10% solution) (Behring Diagnostics, La Jolla, CA) was added and the suspension was incubated for 30 min at 4°C followed by centrifugation for 2 min at 5,000 g. Purified human ADA (11 ,ug) was added to one of the duplicate proband samples and all supernatants were then incubated for 1 h with 2 ,l rabbit anti-ADA antiserum. The Pansorbin precipitation was repeated, all Staphylococcal pellets were washed 3 times with Buffer A, and radiolabeled proteins were liberated by boiling for 4 min in a reducing buffer containing 63 mM Tris, 2% SDS, 10% glycerol, and 5% 2-mercaptoethanol (pH 6.8). The supernatants were electrophoresed in a 10% SDS-polyacrylamide gel that was then fixed, treated with En3Hance, and autoradiographed for 6 d. Cold calf intestinal ADA and 14C-labeled proteins were used as molecular weight standards.
Results
ADA activities in cells from two members of the kindred and controls are shown in Table I . These data confirm the marked elevation in kindred erythrocyte ADA activity compared with that in normal and high-reticulocyte controls (3, 4) . ADA activity in the proband-derived B lymphoblast line is comparable with Fig. 2 . The patterns of restriction fragments and the intensity of bands in the proband are identical to controls. No abnormal bands have been detected on Southern blots in which genomic DNA was digested with randomly chosen restriction endonucleases and enzymes site-specific for DNA corresponding to the 5' noncoding region of ADA mRNA (Alu I, Bal I, BamH I, EcoR I, Mbo I, Msp I, Nci I, Nco I, Pst I, Rsa I, Taq I). In view of these data, it is highly unlikely that gene amplification or major structural alterations in the proband ADA gene account for the increased amounts of ADA enzyme.
Northern blot analysis was used to assess the amount of ADA-specific mRNA in proband reticulocytes (Fig. 3) . The amount of proband ADA mRNA (lane 1) is equivalent to that in RNA obtained from controls with hemolytic anemias (lanes 2-4), suggesting that the defect is not due to increased transcrip- tion of the ADA gene or increased stability of the ADA mRNA in the reticulocyte. Northern blots were repeated with poly A' RNA with similar results (data not shown). Representative blots were reprobed with an alpha-globin cDNA probe (20) to ensure that equal amounts of RNA were loaded and that the RNA was of reticulocyte origin (data not shown). Levels of ADA mRNA were also assessed in proband B lymphoblasts, control B lymphoblasts, and a T lymphoblast line with high ADA activity (Fig. 3) We then asked whether the increased amount ofADA protein in proband erythrocytes resulted from increased translation of the ADA mRNA. Poly A' mRNAs from the proband and a high-reticulocyte control were translated in vitro with incorporation of "S-methionine, immunoprecipitated with anti-ADA antibody, and electrophoresed as described in Methods. Results are shown in Fig. 4 . Translation of proband mRNA produces a band of -42,000 mol wt (arrow, lane 4) that is significantly and specifically reduced in intensity in the presence of 11 g unlabeled human ADA protein (lane 5). This band is not present in proband samples incubated with preimmune serum (lane 3) or in control preimmune or immune precipitations (lanes 1 and  2) . A similar band specific for the translation products ofproband mRNA has been observed in three separate experiments.
Discussion
We have demonstrated that the elevated erythrocyte ADA activity in this kindred is associated with a corresponding increase in the amount of ADA immunoreactive protein. This finding is There have been several examples of mutations reported to affect the translational efficiency ofspecific mRNAs. The degree of secondary structure ofthe 5' noncoding region of the mRNA appears to be inversely proportional to the translational efficiency of the mRNA (23) . For example, rearrangement of the c-myc protooncogene resulting in truncation of the 5' region and the inability to form a stable stem-loop structure has been reported to increase the translation ofc-myc mRNA (24) . This observation is of particular interest because the 5' noncoding region of ADA mRNA is comprised of 80% guanosine and cytosine residues (10, 25, 26) with considerable potential for formation of stable secondary structures. Mutations in this region and consequent loss of secondary structure might result in increased ribosomal binding to and/or scanning of the mRNA. Point mutations flanking the initiation codon have also been shown to alter translational efficiency (27) .
The mechanism underlying the tissue specificity ofthis defect is not yet clear. Inhibitors of translation have been demonstrated in erythroid cells (28) , and one potential mechanism for specific increased translational efficiency of ADA mRNA in red cells is a mutation that prevents the binding of an inhibitor. This possibility is especially intriguing in view of the unexpectedly high abundance of ADA mRNA in normal reticulocytes when compared with the amount in B lymphoblasts that have 50-to 100-fold higher ADA enzymatic activity. It is also possible that tissuespecific splicing of a primary RNA transcript may give rise to minor differences in the 5' noncoding regions of ADA mRNAs that thus affect translational efficiency. Our in vitro translation experiments make the possibility of a trans-acting factor specifically affecting the translation of the ADA mRNA in the red cells of this kindred less likely, because the increase in mRNA translation can be demonstrated in a rabbit reticulocyte system. Further elucidation of the specific defect in this disorder, including the cloning and sequencing of ADA cDNA clones from both reticulocyte and lymphoblast libraries, should provide additional insights into the tissue-specific overproduction of ADA protein.
